Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2019

01-04-2019 | Acute Kidney Injury | Original article

Metabolitic profiling of amino acids in paraquat-induced acute kidney injury

Authors: Xiuxian Wan, XinHua Li, Qiang Wang, Bin Zheng, Chunyu Zhou, Xin Kang, Dayong Hu, Hui Bao, Ai Peng

Published in: Clinical and Experimental Nephrology | Issue 4/2019

Login to get access

Abstract

Background

The herbicide paraquat (1, 1′-dimethyl-4, 4′-bipyridylium dichloride; PQ) is a poison well-known to cause delayed mortality due to acute kidney injuries (AKI). This study examines the changes in serum amino acids (AAs) metabolite profiles as surrogate markers of renal cell metabolism and function after paraquat poisoning.

Methods

To identify the metabolic profiling of free serum AAs and its metabolites, serum from 40 paraquat-poisoned patients with or without AKI is collected. LC-MS/GC-MS is performed to analyze AA molecules. A Cox proportional hazard model was used to assess for incidence of AKI. Receiver operating characteristic (ROC) curve is applied to evaluate AKI occurrence and prognosis.

Results

A total of 102 serum AAs and its metabolites were identified. Compared with non-AKI patients, 37 varied significantly in AKI patients. The univariate Cox proportional hazard model analysis revealed that the estimated PQ amount, plasma PQ concentration, urine PQ concentration, APACHE, SOFA scores and 16 amino acids correlated with the incidence of AKI. Further analyses revealed that 3-methylglutarylcarnitine, 1-methylimidazoleacetate, and urea showed higher cumulative hazard ratios for the occurrence of AKI during follow-up (P < 0.05). The area under the curve (AUC) of 3-methylglutarylcarnitine, 1-methylimidazoleacetate and urea were 0.917, 0.857, 0.872, respectively.

Conclusion

3-methylglutarylcarnitine, 1-methylimidazoleacetate and urea were associated with AKI in patients with paraquat intoxication.
Appendix
Available only for authorised users
Literature
1.
3.
4.
go back to reference Hawksworth GM, Bennett PN, Davies DS. Kinetics of paraquat elimination in the dog. Toxicol Appl Pharmacol. 1981;57(2):139.CrossRefPubMed Hawksworth GM, Bennett PN, Davies DS. Kinetics of paraquat elimination in the dog. Toxicol Appl Pharmacol. 1981;57(2):139.CrossRefPubMed
5.
go back to reference Smith LL. Mechanism of paraquat toxicity in lung and its relevance to treatment. Hum Toxicol. 1987;6(1):31–6.CrossRefPubMed Smith LL. Mechanism of paraquat toxicity in lung and its relevance to treatment. Hum Toxicol. 1987;6(1):31–6.CrossRefPubMed
6.
go back to reference Haley TJ. Review of the toxicology of paraquat (1,1′-dimethyl-4,4′-bipyridinium chloride). Clin Toxicol. 1979;14(1):1–46.CrossRefPubMed Haley TJ. Review of the toxicology of paraquat (1,1′-dimethyl-4,4′-bipyridinium chloride). Clin Toxicol. 1979;14(1):1–46.CrossRefPubMed
7.
go back to reference Lin JL, Liu L, Leu ML. Recovery of respiratory function in survivors with paraquat intoxication. Arch Environ Health. 1995;50(6):432–9.CrossRefPubMed Lin JL, Liu L, Leu ML. Recovery of respiratory function in survivors with paraquat intoxication. Arch Environ Health. 1995;50(6):432–9.CrossRefPubMed
8.
go back to reference Li LR, Sydenham E, Chaudhary B, Beecher D, You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database Syst Rev. 2014(8):Cd008084. Li LR, Sydenham E, Chaudhary B, Beecher D, You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database Syst Rev. 2014(8):Cd008084.
9.
go back to reference Gill N, Nally JV Jr, Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005;128(4):2847–63.CrossRefPubMed Gill N, Nally JV Jr, Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005;128(4):2847–63.CrossRefPubMed
10.
go back to reference Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294(7):813–8.CrossRefPubMed Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294(7):813–8.CrossRefPubMed
11.
go back to reference Molck AM, Friis C. The cytotoxic effect of paraquat to isolated renal proximal tubular segments from rabbits. Toxicology. 1997;122(1–2):123–32.CrossRefPubMed Molck AM, Friis C. The cytotoxic effect of paraquat to isolated renal proximal tubular segments from rabbits. Toxicology. 1997;122(1–2):123–32.CrossRefPubMed
12.
go back to reference Ishii K, Adachi J, Tomita M, Kurosaka M, Ueno Y. Oxysterols as indices of oxidative stress in man after paraquat ingestion. Free Radic Res. 2002;36(2):163–8.CrossRefPubMed Ishii K, Adachi J, Tomita M, Kurosaka M, Ueno Y. Oxysterols as indices of oxidative stress in man after paraquat ingestion. Free Radic Res. 2002;36(2):163–8.CrossRefPubMed
13.
go back to reference Senator A, Rachidi W, Lehmann S, Favier A, Benboubetra M. Prion protein protects against DNA damage induced by paraquat in cultured cells. Free Radic Biol Med. 2004;37(8):1224–30.CrossRefPubMed Senator A, Rachidi W, Lehmann S, Favier A, Benboubetra M. Prion protein protects against DNA damage induced by paraquat in cultured cells. Free Radic Biol Med. 2004;37(8):1224–30.CrossRefPubMed
14.
go back to reference Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol. 2003;23(5):500–8.CrossRefPubMed Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol. 2003;23(5):500–8.CrossRefPubMed
15.
go back to reference Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med. 2000;28(4):1161–5.CrossRef Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med. 2000;28(4):1161–5.CrossRef
16.
go back to reference KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.CrossRef KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.CrossRef
17.
go back to reference Fujii T, Uchino S, Takinami M, Bellomo R. Validation of the kidney disease improving global outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 2014;9(5):848–54.CrossRefPubMedPubMedCentral Fujii T, Uchino S, Takinami M, Bellomo R. Validation of the kidney disease improving global outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 2014;9(5):848–54.CrossRefPubMedPubMedCentral
18.
go back to reference Greene KE, Peters JI. Pathophysiology of acute respiratory failure. Clin Chest Med. 1994;15(1):1–12.PubMed Greene KE, Peters JI. Pathophysiology of acute respiratory failure. Clin Chest Med. 1994;15(1):1–12.PubMed
19.
go back to reference Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl. 2003;47:3 s–14 s.CrossRef Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl. 2003;47:3 s–14 s.CrossRef
20.
go back to reference Lin JL, Leu ML, Liu YC, Chen GH. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med. 1999;159(2):357–60.CrossRefPubMed Lin JL, Leu ML, Liu YC, Chen GH. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med. 1999;159(2):357–60.CrossRefPubMed
21.
go back to reference Hong SY, Gil HW, Yang JO, Lee EY, Na JO, Seo KH, et al. Clinical implications of the ethane in exhaled breath in patients with acute paraquat intoxication. Chest. 2005;128(3):1506–10.CrossRefPubMed Hong SY, Gil HW, Yang JO, Lee EY, Na JO, Seo KH, et al. Clinical implications of the ethane in exhaled breath in patients with acute paraquat intoxication. Chest. 2005;128(3):1506–10.CrossRefPubMed
22.
go back to reference Whitehead RD, Montesano MA, Jayatilaka NK, Buckley B, Winnik B, Needham LL, et al. Method for measurement of the quaternary amine compounds paraquat and diquat in human urine using high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878(27):2548–53.CrossRef Whitehead RD, Montesano MA, Jayatilaka NK, Buckley B, Winnik B, Needham LL, et al. Method for measurement of the quaternary amine compounds paraquat and diquat in human urine using high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878(27):2548–53.CrossRef
23.
go back to reference Zhou CY, Kang X, Li CB, Li XH, Liu Y, Wang Z, et al. Pneumomediastinum predicts early mortality in acute paraquat poisoning. Clin Toxicol (Phila). 2015;53(6):551–6.CrossRef Zhou CY, Kang X, Li CB, Li XH, Liu Y, Wang Z, et al. Pneumomediastinum predicts early mortality in acute paraquat poisoning. Clin Toxicol (Phila). 2015;53(6):551–6.CrossRef
24.
go back to reference Seymour CW, Yende S, Scott MJ, Pribis J, Mohney RP, Bell LN, et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med. 2013;39(8):1423–34.CrossRefPubMedPubMedCentral Seymour CW, Yende S, Scott MJ, Pribis J, Mohney RP, Bell LN, et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med. 2013;39(8):1423–34.CrossRefPubMedPubMedCentral
25.
go back to reference Wunnapuk K, Medley GA, Liu X, Grice JE, Jayasinghe S, Gawarammana I, et al. Simple and sensitive liquid chromatography-tandem mass spectrometry methods for quantification of paraquat in plasma and urine: application to experimental and clinical toxicological studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(28):3047–52.CrossRefPubMed Wunnapuk K, Medley GA, Liu X, Grice JE, Jayasinghe S, Gawarammana I, et al. Simple and sensitive liquid chromatography-tandem mass spectrometry methods for quantification of paraquat in plasma and urine: application to experimental and clinical toxicological studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(28):3047–52.CrossRefPubMed
26.
go back to reference Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, et al. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9(4):383–97.CrossRefPubMed Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, et al. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9(4):383–97.CrossRefPubMed
27.
28.
go back to reference Cox DR. Regression Models and Life-Tables. J Roy Stat Soc. 1972;34(2):187–220. Cox DR. Regression Models and Life-Tables. J Roy Stat Soc. 1972;34(2):187–220.
29.
go back to reference Li LR, Sydenham E, Chaudhary B, You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database Syst Rev. 2014;8(6):-. Li LR, Sydenham E, Chaudhary B, You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database Syst Rev. 2014;8(6):-.
30.
go back to reference Roe CR, Millington DS, Maltby DA. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J Clin Investig. 1986;77(4):1391.CrossRefPubMed Roe CR, Millington DS, Maltby DA. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J Clin Investig. 1986;77(4):1391.CrossRefPubMed
31.
33.
go back to reference Borum PR. Carnitine. Determination of total carnitine using a radioenzymatic assay. J Nutr Biochem. 1990;1(2):111.CrossRefPubMed Borum PR. Carnitine. Determination of total carnitine using a radioenzymatic assay. J Nutr Biochem. 1990;1(2):111.CrossRefPubMed
34.
go back to reference Hermann K, Hertenberger B, Ring J. Measurement and characterization of histamine and methylhistamine in human urine under histamine-rich and histamine-poor diets. Int Arch Allergy Immunol. 1993;101(1):13–9.CrossRefPubMed Hermann K, Hertenberger B, Ring J. Measurement and characterization of histamine and methylhistamine in human urine under histamine-rich and histamine-poor diets. Int Arch Allergy Immunol. 1993;101(1):13–9.CrossRefPubMed
35.
go back to reference Johansson AC, Lönnqvist B, Granerus G. The relationship between body size and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid in man. Inflamm Res. 2001;50(2):70–1. Johansson AC, Lönnqvist B, Granerus G. The relationship between body size and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid in man. Inflamm Res. 2001;50(2):70–1.
36.
go back to reference Johansson AC, Lonnqvist B, Granerus G. The relationship between body size and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid in man. Inflamm Res. 2001;50(Suppl 2):70-1. Johansson AC, Lonnqvist B, Granerus G. The relationship between body size and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid in man. Inflamm Res. 2001;50(Suppl 2):70-1.
37.
go back to reference Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol Immunol. 2015;63(1):86–93.CrossRefPubMed Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol Immunol. 2015;63(1):86–93.CrossRefPubMed
38.
go back to reference Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Investig J Tech Methods Pathol. 2012;92(10):1472.CrossRef Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Investig J Tech Methods Pathol. 2012;92(10):1472.CrossRef
39.
go back to reference Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol Immunol. 2014. Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol Immunol. 2014.
40.
go back to reference Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Invest. 2012;92(10):1472–82.CrossRefPubMedPubMedCentral Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ. Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Invest. 2012;92(10):1472–82.CrossRefPubMedPubMedCentral
41.
go back to reference Moore AE, Johnston WH, Hever A, Peng S, Kujubu DA. Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature. Int Urol Nephrol. 2012;44(2):639–42.CrossRefPubMed Moore AE, Johnston WH, Hever A, Peng S, Kujubu DA. Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature. Int Urol Nephrol. 2012;44(2):639–42.CrossRefPubMed
42.
go back to reference Talaszka A, Boulanger E, Le Monies de Sagazan H, Le Blan C. Acute kidney failure revealing mastocytosis. Presse Med. 1992;21(19):908–9.PubMed Talaszka A, Boulanger E, Le Monies de Sagazan H, Le Blan C. Acute kidney failure revealing mastocytosis. Presse Med. 1992;21(19):908–9.PubMed
43.
go back to reference Fenton RA, Knepper MA. Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol Jasn. 2007;18(3):679–88.CrossRefPubMed Fenton RA, Knepper MA. Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol Jasn. 2007;18(3):679–88.CrossRefPubMed
44.
go back to reference Varela CF, Greloni G, Schreck C, Bratti G, Medina A, Marenchino R, et al. Assessment of fractional excretion of urea for early diagnosis of cardiac surgery associated acute kidney injury. Ren Fail. 2015;37(10):327–31.CrossRefPubMed Varela CF, Greloni G, Schreck C, Bratti G, Medina A, Marenchino R, et al. Assessment of fractional excretion of urea for early diagnosis of cardiac surgery associated acute kidney injury. Ren Fail. 2015;37(10):327–31.CrossRefPubMed
45.
go back to reference Fenton RA, Knepper MA. Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol. 2007;18(3):679–88.CrossRefPubMed Fenton RA, Knepper MA. Urea and renal function in the 21st century: insights from knockout mice. J Am Soc Nephrol. 2007;18(3):679–88.CrossRefPubMed
46.
Metadata
Title
Metabolitic profiling of amino acids in paraquat-induced acute kidney injury
Authors
Xiuxian Wan
XinHua Li
Qiang Wang
Bin Zheng
Chunyu Zhou
Xin Kang
Dayong Hu
Hui Bao
Ai Peng
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 4/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01702-z

Other articles of this Issue 4/2019

Clinical and Experimental Nephrology 4/2019 Go to the issue